Related Experiment Video
Updated: Aug 30, 2025

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
Published on: July 22, 2016
Emerging Roles of NANOS RNA-Binding Proteins in Cancer
Erkut Ilaslan1, Marcin Piotr Sajek1,2,3, Jadwiga Jaruzelska1
1Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Abstract:
In recent years, growing evidence demonstrates that mammalian Nanos RNA-binding proteins (Nanos1, Nanos2, and Nanos3), known for their indispensable roles in germline development, are overexpressed in a variety of cancers. This overexpression contributes to various oncogenic properties including cancer growth, invasiveness, and metastasis. Here, we highlight recent findings regarding the role of mammalian Nanos RNA-binding proteins and the mechanisms of their overexpression in cancer. In addition, we present expression profiles of human NANOS genes and their oncogenic transcriptional regulators obtained from publicly available cancer and normal tissue RNA-Seq datasets. Altogether, we emphasize the functional significance of NANOS proteins across human cancers as well as highlight the missing links to understanding the full scope of their role in carcinogenesis.
Insights
Mammalian Nanos RNA-binding proteins are overexpressed in cancers, promoting tumor growth and metastasis. Understanding their role in carcinogenesis is crucial for cancer therapy development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Mammalian Nanos RNA-binding proteins (Nanos1, Nanos2, Nanos3) are essential for germline development.
- Recent studies indicate Nanos protein overexpression in various human cancers.
- This overexpression is linked to oncogenic properties like cancer growth, invasiveness, and metastasis.
Purpose of the Study:
- To review recent findings on the role of mammalian Nanos proteins in cancer.
- To explore mechanisms behind Nanos protein overexpression in cancer.
- To analyze expression profiles of human NANOS genes and their regulators in cancer.
Main Methods:
- Literature review of recent findings on Nanos proteins in cancer.
- Analysis of publicly available RNA-Seq datasets for human cancer and normal tissues.
- Examination of expression profiles for NANOS genes and oncogenic transcriptional regulators.
Main Results:
- Nanos proteins play significant roles in promoting cancer progression.
- Overexpression of Nanos proteins is a common event in various malignancies.
- Expression patterns of NANOS genes and regulators vary across different cancer types.
Conclusions:
- Nanos proteins are functionally significant across human cancers.
- Further research is needed to fully elucidate the role of Nanos proteins in carcinogenesis.
- Targeting Nanos proteins may offer potential therapeutic strategies for cancer treatment.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
The Nucleolus
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

